Tag: #Global Trends

Key Development The U.S. Supreme Court has delivered a landmark legal victory to German life sciences conglomerate Bayer, issuing a... Read more

Key Development The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion... Read more

Key Development The European Commission (EC) has officially initiated formal antitrust proceedings against French pharmaceutical giant Sanofi. This major regulatory... Read more

Key Development Global healthcare leader Organon (NYSE: OGN) has formally executed an exclusive global licensing agreement with Sebela Pharmaceuticals, securing... Read more

Key Development Global science and technology leader Merck KGaA has entered into a strategic research-stage collaboration with Saturnus Bio, a... Read more

Key Development At the BIO International Convention 2026 in San Diego, leading contract development and manufacturing organization (CDMO) SK pharmteco... Read more

Key Development Swiss healthcare conglomerate Novartis has formalized a high-stakes strategic partnership valued at up to $1.9 billion with U.S.-based... Read more

Key Development U.S. pharmaceutical powerhouse Eli Lilly is finalizing its regulatory and commercial strategy to launch Orforglipron—its novel, once-daily oral... Read more

Key Development Dutch technology investment conglomerate Prosus has finalized a $460 million investment round into the French healthtech trailblazer Alan,... Read more